Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts, CSF shunts, Lumbar fusion, Bone graft & orthobiologics, Cholecystectomy & appendectomy, Hernia repair, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
The same products and surgeons under a new company (Smith+Nephew): expect new reps and contracts, and ask what changed for them.
Source · closing date to confirm
Payments and FDA records read by the company that owns the business today, so a deal never looks like surgeons switching; a surgeon’s payment history still shows the name each payment was made under.
In the last ten years FDA made 68 decisions for Integra LifeSciences (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 6 procedure families, the most in 2019 (13). The latest was on 2026-09-18.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 117 |
| CSF shunts | 37 |
| Lumbar fusion | 6 |
| Bone graft & orthobiologics | 5 |
| Cholecystectomy & appendectomy | 1 |
| Hernia repair | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-18 | PMA | P900033-S117 | INTEGRA ® Dermal Regeneration Template, Integra® Meshed Dermal Regeneration Template, and Integra® Omnigraft Dermal Rege · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-06-23 | 510(k) | K261004 | Codman® Distal Peritoneal Catheter, Barium Open End (82-1682); Codman® HOLTER® Peritoneal Catheter (SALMON Design) (82-1684) |
| 2026-02-25 | PMA | P900033-S116 | INTEGRA ® Dermal Regeneration Template; Integra® Meshed Dermal Regeneration Template; Integra® Omnigraft Dermal Regenera · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-09-09 | PMA | P900033-S115 | INTEGRA® Dermal Regeneration Template, Integra® Meshed Dermal Regeneration Template, and Integra® Omnigraft Dermal Regen · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-08-08 | 510(k) | K243531 | Codman Libertís Shunt Catheter with Bactiseal and Endexo Technology |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Integra LifeSciences.
In 2025, Integra LifeSciences reported engagement with 11,539 surgeons and other clinicians in the states MedaRep covers, worth $3.0M in consulting, speaking, meals and travel for its device products, the most in California ($311K to 1,133). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($311K, 1,133 engaged), Florida ($290K, 1,075 engaged), Pennsylvania ($210K, 441 engaged), Ohio ($189K, 471 engaged), Texas ($181K, 1,209 engaged).